16 results on '"M. Provencio"'
Search Results
2. EP16.04-014 NTRK in Lung Cancer Patients with History of Hodgkin's Lymphoma.
3. 1371PFinal results of RENO study: Randomized phase II of oral vinorelbine or etoposide with cisplatin & chemo-radiation in stage III NSCLC - SLCG 10/02.
4. 66P PALB2 mRNA expression as a predictive marker in advanced non-small cell lung cancer (NSCLC) patients (p) treated with docetaxel-cisplatin.
5. 156P ASTRIS, a real-world study with osimertinib in patients with non-small cell lung cancer (NSCLC) EGFR T790M mutated: Characteristics and diagnostic methods used for patients included in Spain.
6. LBA50 Analysis of pathological features and efficacy outcomes with neoadjuvant nivolumab (N) plus platinum-doublet chemotherapy (C) for resectable non-small cell lung cancer (NSCLC) in CheckMate 816.
7. 939P Changes in immune gene signatures after neoadjuvant chemoimmunotherapy treatment in NSCLC patients from NADIM trial.
8. 947P Follow-up tests' profitability in NSCLC: Experience of a tertiary hospital.
9. 59P Real-world data of immunotherapy in patients over 65 years old with lung cancer.
10. 1380P Description of the clinical characteristics and survival in patients with metastatic NSCLC in the Spanish population: An analysis of the thoracic tumours registry (RTT study).
11. 1275P Extended follow-up of DURVAST trial: A phase II study evaluating durvalumab treatment in HIV-1-infected patients with solid tumours by the Spanish lung cancer group.
12. 4PProspective study of circulating tumor cells in long survivors of immunotherapy.
13. 1890TiPRING observational trial to compare T790M mutation testing in blood by different methodologies.
14. 1525PPalliative care in advanced cancer: A clinical and ethical goal achieved?
15. Experience with fulvestrant acetate in castration-resistant prostate cancer patients.
16. 3511 POSTER Epidemiology of Febrile Neutropenia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.